Trial intelligence / Profile preview

Low-dose imipramine versus standard-dose desmopressin for nocturnal enuresis in children

IRCT2016082129459N1Phase 3Completed

Sponsor
Vice Chancellor for research of Mashhad University of Medical Sciences
Start
Aug 2016
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3 trial of imipramine and desmopressin in nocturnal enuresis (NE) (2 arms), sponsored by Vice Chancellor for research of Mashhad University of Medical Sciences. Started Aug 2016; status: completed.

02

Drugs

imipraminedesmopressin
03

Conditions

nocturnal enuresis (NE)

Beyond the preview

Go deeper on IRCT2016082129459N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016082129459N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call